- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 270457, 5 pages
Urine Cell-Free DNA Integrity as a Marker for Early Prostate Cancer Diagnosis: A Pilot Study
1IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRCCS IRST), Via P. Maroncelli 40,47014 Meldola, Italy
2Department of Urology, Morgagni Pierantoni Hospital, Via C. Forlanini 34, 47121 Forli, Italy
Received 19 October 2012; Revised 8 January 2013; Accepted 9 January 2013
Academic Editor: Tavan Janvilisri
Copyright © 2013 Valentina Casadio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [13 citations]
The following is the list of published articles that have cited the current article.
- Bernhard Ralla, Carsten Stephan, Sebastian Meller, Dimo Dietrich, Glen Kristiansen, and Klaus Jung, “Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies*,” Critical Reviews in Clinical Laboratory Sciences, pp. 1–32, 2014.
- Wanlong Ma, Kevin Diep, Herbert A. Fritsche, Neal Shore, and Maher Albitar, “Diagnostic and Prognostic Scoring System for Prostate Cancer Using Urine and Plasma Biomarkers,” Genetic Testing and Molecular Biomarkers, pp. 140210075529009, 2014.
- Seok Joong Yun, Chunri Yan, Pildu Jeong, Ho Won Kang, Ye-Hwan Kim, Eun-Ah Kim, Ok-Jun Lee, Won Tae Kim, Sung-Kwon Moon, Isaac Yi Kim, Yung-Hyun Choi, and Wun-Jae Kim, “Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH,” Annals of Surgical Oncology, 2014.
- Kewen Zheng, Yaling Dou, Linfu He, Hanzhong Li, Zhicai Zhang, Yu Chen, Ali Ye, Wenjing Liu, and Lingjun Kong, “Improved sensitivity and specificity for prostate cancer diagnosis based on the urine PCA3/PSA ratio acquired by sequence‑specific RNA capture,” Oncology Reports, 2015.
- David M. Hyman, Eli L. Diamond, Cecile Rose T. Vibat, Latifa Hassaine, Jason C. Poole, Minal Patel, Veronica R. Holley, Goran Cabrilo, Timothy T. Lu, Maria E. Arcila, Young Rock Chung, Raajit Rampal, Mario E. Lacouture, Neal Rosen, Funda Meric-Bernstam, Jose Baselga, Razelle Kurzrock, Mark G. Erlander, Filip Janku, and Omar Abdel-Wahab, “Prospective Blinded Study of BRAF(V600E) Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders,” Cancer Discovery, vol. 5, no. 1, pp. 64–71, 2015.
- Wei-Lun Huang, Fang Wei, David T. Wong, Chien-Chung Lin, and Wu-Chou Su, “The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer,” BioMed Research International, vol. 2015, pp. 1–10, 2015.
- Samanta Salvi, Giorgia Gurioli, Filippo Martignano, Flavia Foca, Roberta Gunelli, Giacomo Cicchetti, Ugo De Giorgi, Wainer Zoli, Daniele Calistri, and Valentina Casadio, “Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients,” Disease Markers, vol. 2015, pp. 1–6, 2015.
- Chunri Yan, Ye-Hwan Kim, Ho Won Kang, Sung Phil Seo, Pildu Jeong, Il-Seok Lee, Dongho Kim, Jung Min Kim, Yung Hyun Choi, Sung-Kwon Moon, Seok Joong Yun, and Wun-Jae Kim, “ Urinary Nucleic Acid TSPAN13 -to- S100A9 Ratio as a Diagnostic Marker in Prostate Cancer ,” Journal of Korean Medical Science, vol. 30, no. 12, pp. 1784, 2015.
- S. Chen, J. Zhao, L. Cui, and Y. Liu, “Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs,” Clinical and Translational Oncology, 2016.
- Wendy (Shuwen) He, and Karen Suzanne Bishop, “The potential use of cell-free-circulating-tumor DNA as a biomarker for prostate cancer,” Expert Review of Molecular Diagnostics, pp. 1–14, 2016.
- Jeffrey J. Tosoian, Ashley E. Ross, Lori J. Sokoll, Alan W. Partin, and Christian P. Pavlovich, “Urinary Biomarkers for Prostate Cancer,” Urologic Clinics of North America, vol. 43, no. 1, pp. 17–38, 2016.
- Xiu-Qin Shi, Wen-Hua Xue, Song-Feng Zhao, Xiao-Jian Zhang, and Wukong Sun, “Dynamic tracing for epidermal growth factor receptor mutations in urinary circulating DNA in gastric cancer patients,” Tumor Biology, vol. 39, no. 2, pp. 101042831769168, 2017.
- Ludmila A. Alekseeva, Nadezhda L. Mironova, Evgenyi V. Brenner, Alexander M. Kurilshikov, Olga A. Patutina, and Marina A. Zenkova, “Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment,” Plos One, vol. 12, no. 2, pp. e0171988, 2017.